financetom
Business
financetom
/
Business
/
PhonePe hits 250 mn user mark, registers 925 mn transactions in October
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PhonePe hits 250 mn user mark, registers 925 mn transactions in October
Nov 2, 2020 4:28 AM

Flipkart-owned fintech platform PhonePe on Monday said it has crossed the 250 million registered user milestone. The company reported over 100 million monthly active users (MAU) and 2.3 billion app sessions in October, a statement said. ”PhonePe had a record month in October, processing 925 million transactions – its highest so far – with an annual TPV (total payment volume) run rate of USD 277 billion. PhonePe also processed 835 million UPI transactions in October, for a market-leading share of over 40 percent,” it added.

Sameer Nigam, CEO and founder of PhonePe, said the company has set a target of crossing 500 million registered users by December 2022. ”In line with our brand ethos of ’Karte Ja. Badhte Ja’, we continue to launch new and innovative products for every strata of Indian society, as well as enable digital payment acceptance across every merchant in every village and town in India,” he added.

PhonePe – which competes with the likes of Paytm, MobiKwik and Google Pay – allows users to send and receive money, recharge mobile and make utility payments as well as buy gold and make investments. It had also launched its ’Switch’ platform that allows customers can place orders on over 220 apps including Ola, Myntra, IRCTC, Goibibo, RedBus and Oyo.

Also Read

: Paytm Postpaid aims to double postpaid service users to 1.5 cr by March 2021

PhonePe is accepted at 13 million merchant outlets across 500 cities nationally.

First Published:Nov 2, 2020 1:28 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Meta Platforms CEO Allegedly Knew Use of 'Pirated Copyrighted' Data to Train AI, Writers Say
Meta Platforms CEO Allegedly Knew Use of 'Pirated Copyrighted' Data to Train AI, Writers Say
Jan 10, 2025
08:17 AM EST, 01/10/2025 (MT Newswires) -- Meta Platforms ( META ) and Chief Executive Mark Zuckerberg knowingly used pirated copyrighted works to program its artificial intelligence datasets, according to writers suing the tech giant. In a court document filed Wednesday, the plaintiffs alleged that internal Meta records show that Zuckerberg approved the use of LibGen data despite concerns from...
BRIEF-ESSA Bancorp May Pay $8.8 Mln Termination Fee If Merger Not Consummated
BRIEF-ESSA Bancorp May Pay $8.8 Mln Termination Fee If Merger Not Consummated
Jan 10, 2025
Jan 10 (Reuters) - ESSA Bancorp Inc ( ESSA ): * ESSA BANCORP ( ESSA ) - MAY PAY $8.8 MILLION TERMINATION FEE IF MERGER NOT CONSUMMATED - SEC FILING Source text: https://shorturl.at/D15sM Further company coverage: ...
Lantronix Names Brent Stringham Chief Financial Officer
Lantronix Names Brent Stringham Chief Financial Officer
Jan 10, 2025
08:12 AM EST, 01/10/2025 (MT Newswires) -- Lantronix ( LTRX ) said Friday it has named Brent Stringham as chief financial officer. Stringham previously was Lantronix's ( LTRX ) interim CFO and chief accounting officer, the company added. Shares of Lantronix ( LTRX ) rose 8.3% in recent Friday premarket activity. ...
Vertex, Zai Lab Partner Over Povetacicept Development in China, 4 Other Regions
Vertex, Zai Lab Partner Over Povetacicept Development in China, 4 Other Regions
Jan 10, 2025
08:13 AM EST, 01/10/2025 (MT Newswires) -- Vertex Pharmaceuticals ( VRTX ) and Zai Lab ( ZLAB ) said Friday they have signed a licensing deal to develop and commercialize povetacicept in mainland China, Hong Kong, Macau, Taiwan, and Singapore. Zai Lab ( ZLAB ) will oversee clinical trials, regulatory submissions, and marketing in the licensed territory, the companies said....
Copyright 2023-2026 - www.financetom.com All Rights Reserved